Advanced Search

Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 June;52(2) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 June;52(2):101-6

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUETHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging

A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 1,724

Frequency: Quarterly

ISSN 1824-4785

Online ISSN 1827-1936

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 June;52(2):101-6

NON-STANDARD PET NUCLIDES 

    FOREWORD

Workshop on the production, application and clinical translation of “non-standard” PET nuclides: a meeting report

Lewis J. S., Welch M. J., Tang L.

Mallinckrodt Institute of Radiology, Division of Radiological Sciences Alvin J. Siteman Cancer Center Washington University School of Medicine St. Louis, MO, USA

A one-day satellite workshop was organized to coincide with the 17th International Symposium on Radiopharmaceutical Sciences held in Aachen, Germany, April 30-May 4, 2007. The workshop, “Production and application of ‘non-standard’ PET nuclides”, was held on Sunday April 29, 2007 at the Eurogress Aachen and was organized by J. Lewis, PhD, L. Tang, and M. Welch, PhD. The workshop was designed for the radiopharmaceutical community discussing the production, use and dissemination of the “non-standard” PET nuclides. The definition of “non-standard” positron emission tomography (PET) nuclides included 45Ti, 60Cu, 61Cu, 64Cu, 66Ga, 72As, 74As, 76Br, 86Y, 89Zr, 94mTc and 124I. The workshop was supported by the grant Research Resource for Cancer Applications (R24 CA86307) funded by the National Cancer Institute at the National Institutes of Health. The workshop was attended by over 110 scientists and engineers from over 20 countries from all over the world and was designed with an open forum style to allow for discussions and interactions by all participants. All of the invited speakers were asked to make a contribution to this edition of the Quarterly Journal of Nuclear Medicine. The individual articles following this introduction are reviews of their area of expertise and the current state-of-the-art. This introduction briefly describes the role of the workshop, the aims and the general outcome. Also, the translation of these nuclides to the clinic, perhaps the most important goal of this work is discussed in this introductory article.

language: English


FULL TEXT  REPRINTS

top of page